Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2026 FYStats. 
Home
Equities
GANX
Fundamentals

Gain Therapeutics, Inc.

GANX

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

55.18k
▲180.35k▲144.08%
3 Months Change

Assets

10.97M
▲1.14M▲11.57%
3 Months Change

Liabilities

5.06M
▼-1.08M▼-17.53%
3 Months Change

Free Cash Flow

-4.23M
▼-1.77M▼-72.22%
12 Months Change

Revenue/Cost Of Revenue

Loading...

Net Profit/Loss

Loading...

Assets/Liabilities

Loading...

Cash Flows

Loading...

Earnings Per Share

Loading...

Outstanding Shares

Loading...

Recent Quarterly and Annual Filings

2026-02-03
Form 8-K
ID: 0001104659-26-009747
2025-12-18
Form 8-K
ID: 0001104659-25-122353
2025-11-28
Form 8-K
ID: 0001104659-25-116947
2025-11-12
Form 10-Q
ID: 0001104659-25-110347
2025-11-12
Form 8-K
ID: 0001104659-25-110343
2025-10-14
Form 8-K
ID: 0001104659-25-099343
2025-10-09
Form 8-K
ID: 0001104659-25-098376
2025-10-06
Form 8-K
ID: 0001104659-25-097153
2025-08-12
Form 10-Q
ID: 0001558370-25-011220
2025-08-12
Form 8-K
ID: 0001558370-25-011218